Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Targeted Therapies in Elderly Patients (Over 5 and 75 Year-old) With Metastatic Melanoma

NCT03155217 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03155217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03155217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Targeted Therapies in Elderly Patients (Over 5 and 75 Year-old) With Metastatic Melanoma
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
May 5, 2017
Completion date
December 31, 2018
Enrollment
358 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma